Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439082
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-27
Brief Title:
A Study to Investigate the Efficacy and Safety of Crizanlizumab 5 mgkg Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises SPARKLE
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-03-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-04-19
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-27
First Submit QC Date:
May 27 2024
Study First Post Date:
2024-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-27
Last Update Post Date:
2024-06-03
Last Update Post Date Type:
ACTUAL